170 related articles for article (PubMed ID: 11799848)
1. Molecular factors affecting the complex formation between deferiprone (L1) and Cu(II). Possible implications on efficacy and toxicity.
Pashalidis I; Kontoghiorghes GJ
Arzneimittelforschung; 2001; 51(12):998-1003. PubMed ID: 11799848
[TBL] [Abstract][Full Text] [Related]
2. Interactions of hydroxycarbamide (hydroxyurea) with iron and copper: implications on toxicity and therapeutic strategies.
Konstantinou E; Pashalidis I; Kolnagou A; Kontoghiorghes GJ
Hemoglobin; 2011; 35(3):237-46. PubMed ID: 21599436
[TBL] [Abstract][Full Text] [Related]
3. Competition between deferiprone, desferrioxamine and other chelators for iron and the effect of other metals.
Sheppard LN; Kontoghiorghes GJ
Arzneimittelforschung; 1993 Jun; 43(6):659-63. PubMed ID: 8352819
[TBL] [Abstract][Full Text] [Related]
4. Copper complexation by 3-hydroxypyridin-4-one iron chelators: structural and iron competition studies.
el-Jammal A; Howell PL; Turner MA; Li N; Templeton DM
J Med Chem; 1994 Feb; 37(4):461-6. PubMed ID: 7509878
[TBL] [Abstract][Full Text] [Related]
5. Complex formation equilibria of Cu(II) and Zn(II) with triethylenetetramine and its mono- and di-acetyl metabolites.
Nurchi VM; Crisponi G; Crespo-Alonso M; Lachowicz JI; Szewczuk Z; Cooper GJ
Dalton Trans; 2013 May; 42(17):6161-70. PubMed ID: 23202417
[TBL] [Abstract][Full Text] [Related]
6. Potentiometric, spectrophotometric and calorimetric study on iron(III) and copper(II) complexes with 1,2-dimethyl-3-hydroxy-4-pyridinone.
Nurchi VM; Crisponi G; Pivetta T; Donatoni M; Remelli M
J Inorg Biochem; 2008 Apr; 102(4):684-92. PubMed ID: 18061272
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, potentiometric, kinetic, and NMR Studies of 1,4,7,10-tetraazacyclododecane-1,7-bis(acetic acid)-4,10-bis(methylenephosphonic acid) (DO2A2P) and its complexes with Ca(II), Cu(II), Zn(II) and lanthanide(III) ions.
Kálmán FK; Baranyai Z; Tóth I; Bányai I; Király R; Brücher E; Aime S; Sun X; Sherry AD; Kovács Z
Inorg Chem; 2008 May; 47(9):3851-62. PubMed ID: 18380456
[TBL] [Abstract][Full Text] [Related]
8. Iron chelation properties of an extracellular siderophore exochelin MN.
Dhungana S; Miller MJ; Dong L; Ratledge C; Crumbliss AL
J Am Chem Soc; 2003 Jun; 125(25):7654-63. PubMed ID: 12812507
[TBL] [Abstract][Full Text] [Related]
9. Cu(II) complex formation by ACES buffer.
Zawisza I; Rózga M; Poznański J; Bal W
J Inorg Biochem; 2013 Dec; 129():58-61. PubMed ID: 24077022
[TBL] [Abstract][Full Text] [Related]
10. Iron(III)- and copper(II) complexes of an asymmetric, pentadentate salen-like ligand bearing a pendant carboxylate group.
Jancsó A; Paksi Z; Mikkola S; Rockenbauer A; Gajda T
J Inorg Biochem; 2005 Jul; 99(7):1480-9. PubMed ID: 15927258
[TBL] [Abstract][Full Text] [Related]
11. The design and development of deferiprone (L1) and other iron chelators for clinical use: targeting methods and application prospects.
Kontoghiorghes GJ; Pattichis K; Neocleous K; Kolnagou A
Curr Med Chem; 2004 Aug; 11(16):2161-83. PubMed ID: 15279556
[TBL] [Abstract][Full Text] [Related]
12. Complexation models of N-(2-carboxyethyl)chitosans with copper(II) ions.
Skorik YA; Gomes CA; Podberezskaya NV; Romanenko GV; Pinto LF; Yatluk YG
Biomacromolecules; 2005; 6(1):189-95. PubMed ID: 15638520
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, Characterization, and Cu(2+) Coordination Studies of a 3-Hydroxy-4-pyridinone Aza Scorpiand Derivative.
López-Martínez LM; Pitarch-Jarque J; Martínez-Camarena À; García-España E; Tejero R; Santacruz-Ortega H; Navarro RE; Sotelo-Mundo RR; Leyva-Peralta MA; Doménech-Carbó A; Verdejo B
Inorg Chem; 2016 Aug; 55(15):7564-75. PubMed ID: 27433814
[TBL] [Abstract][Full Text] [Related]
14. Intramolecular stacking interactions in ternary copper(II) complexes formed by a heteroaromatic amine and 9-[2-(2-phosphonoethoxy)ethyl]adenine, a relative of the antiviral nucleotide analogue 9-[2-(phosphonomethoxy)ethyl]adenine.
Fernández-Botello A; Holý A; Moreno V; Sigel H
J Inorg Biochem; 2004 Dec; 98(12):2114-24. PubMed ID: 15541501
[TBL] [Abstract][Full Text] [Related]
15. The fenton activity of iron(III) in the presence of deferiprone.
Devanur LD; Neubert H; Hider RC
J Pharm Sci; 2008 Apr; 97(4):1454-67. PubMed ID: 17724662
[TBL] [Abstract][Full Text] [Related]
16. Studies on the interaction of olive cake and its hydrophylic extracts with polyvalent metal ions (Cu(II), Eu(III)) in aqueous solutions.
Konstantinou M; Kolokassidou K; Pashalidis I
J Hazard Mater; 2009 Jul; 166(2-3):1169-73. PubMed ID: 19135296
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of quantitative probes for weaker Cu(i) binding sites completes a set of four capable of detecting Cu(i) affinities from nanomolar to attomolar.
Xiao Z; Gottschlich L; van der Meulen R; Udagedara SR; Wedd AG
Metallomics; 2013 May; 5(5):501-13. PubMed ID: 23579336
[TBL] [Abstract][Full Text] [Related]
18. Interactions of quercetin with iron and copper ions: complexation and autoxidation.
El Hajji H; Nkhili E; Tomao V; Dangles O
Free Radic Res; 2006 Mar; 40(3):303-20. PubMed ID: 16484047
[TBL] [Abstract][Full Text] [Related]
19. Complex forming competition and in-vitro toxicity studies on the applicability of di-2-pyridylketone-4,4,-dimethyl-3-thiosemicarbazone (Dp44mT) as a metal chelator.
Gaál A; Orgován G; Polgári Z; Réti A; Mihucz VG; Bősze S; Szoboszlai N; Streli C
J Inorg Biochem; 2014 Jan; 130():52-8. PubMed ID: 24176919
[TBL] [Abstract][Full Text] [Related]
20. Thermodynamics of self-assembly of copper(II) 15-metallacrown-5 of Eu(III) or Gd(III) with (S)-alpha-alaninehydroxamic acid in aqueous solution.
Dallavalle F; Remelli M; Sansone F; Bacco D; Tegoni M
Inorg Chem; 2010 Feb; 49(4):1761-72. PubMed ID: 20078104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
